Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.

about

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.

Item

http://www.wikidata.org/entity/Q54974227

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@en

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@nl

type

Item

label

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@en

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@nl

prefLabel

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@en

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson.

@nl

P1476

Inhibition of IL-17 and IL-23 ...... Receptor Agonist Piclidenoson

@en

P2093

Faina Barer

http://www.w3.org/2001/XMLSchema#string

Inbal Itzhak

http://www.w3.org/2001/XMLSchema#string

Michael H Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.

Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial.

Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions.

P304

2310970

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/2310970

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Pnina Fishman

Shira Cohen

P577

2018-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29862305

http://www.w3.org/2001/XMLSchema#string

P932

5976987

http://www.w3.org/2001/XMLSchema#string